GGT-2 ?-GLUTAMYLTRANSFERASE VER.2 - STANDARDIZED AGAINST SZASZ 03002721122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-08-29 for GGT-2 ?-GLUTAMYLTRANSFERASE VER.2 - STANDARDIZED AGAINST SZASZ 03002721122 manufactured by Roche Diagnostics.

Event Text Entries

[119112830] The event occurred in: (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[119112831] The customer originally complained about questionable crep2 creatinine plus ver. 2 tested on both a cobas 6000 c (501) module and a cobas 8000 (unspecified module) compared to an abbott system. From the data provided, a reportable malfunction was provided for crep2, astlp aspartate aminotransferase acc. To ifcc with pyridoxal phosphate activation, altlp alanine aminotransferase acc. To ifcc with pyridoxal phosphate activation, and ggt-2 -glutamyltransferase ver. 2 standardized against ifcc / szasz. This medwatch will cover ggt-2. Please refer to the medwatch with (b)(6) for information on astlp. Please refer to the medwatch with (b)(6) for information on crep2. Please refer to the medwatch with (b)(6) for information on altlp. The erroneous results were released outside of the laboratory. The patient was sent to the hospital due to the initial high crep2 result, but there was no allegation that the patient was adversely affected. The cobas c501 serial (b)(4). The customer did not provide any specific information on the cobas 8000 system. A preliminary assessment of the case stated that based on previous electrophoresis testing of the patient, the patient is believed to have an interfering factor present. The investigation is currently ongoing.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2018-02915
MDR Report Key7827934
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-08-29
Date of Report2018-10-08
Date of Event2018-08-09
Date Mfgr Received2018-08-10
Date Added to Maude2018-08-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameGGT-2 ?-GLUTAMYLTRANSFERASE VER.2 - STANDARDIZED AGAINST SZASZ
Generic NameGAMMA-GLUTAMYL TRANSPEPTIDASE AND ISOENZYMES TEST SYSTEM
Product CodeJQB
Date Received2018-08-29
Model NumberNA
Catalog Number03002721122
Lot NumberASKU
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-08-29

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.